1. Adamczyk-Sowa M, Pierzchala K, Sowa P, Mucha S, Sadowska-Bartosz I, Adamczyk J, Hartel M (2014a) Melatonin acts as antioxidant and improves sleep in MS patients. Neurochem Res 39(8):1585–1593. https://doi.org/10.1007/s11064-014-1347-6
2. Adamczyk-Sowa M, Galiniak S, Zyracka E, Grzesik M, Naparło K, Sowa P, Bartosz G, Sadowska-Bartosz I (2017) Oxidative modification of blood serum proteins in multiple sclerosis after interferon beta and melatonin treatment. Oxidative Med Cell Longev. https://doi.org/10.1155/2017/7905148
3. Adamczyk-Sowa M, Pierzchala K, Sowa P, Polaniak R, Kukla M, Hartel M (2014b) Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients. J Physiol Pharmacol 65(4), 543–550. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med11&NEWS=N&AN=25179086
4. Adamczyk-Sowa M, Sowa P, Adamczyk J, Niedziela N, Misiolek H, Owczarek M, Zwirska-Korczala K (2016a) Effect of melatonin supplementation on plasma lipid hydroperoxides, homocysteine concentration and chronic fatigue syndrome in multiple sclerosis patients treated with interferons-beta and mitoxantrone. J Physiol Pharmacol 67(2), 235–242. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med13&NEWS=N&AN=27226183
5. Adamczyk-Sowa M, Sowa P, Mucha S, Zostawa J, Mazur B, Owczarek M, Pierzchala K (2016b) Changes in serum ceruloplasmin levels based on immunomodulatory treatments and melatonin supplementation in multiple sclerosis patients. Med Sci Monitor 22:2484–2491. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med13&NEWS=N&AN=27420299https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958372/pdf/medscimonit-22-2484.pdf